Talking about life and IBD: A paradigm for improving patient-physician communication

Journal of Crohn's and Colitis

Volumn 3, Issue 1, 2009, Pages 1-3

  Mitchell, Rod ^a   Kremer, Arjan ^a   Westwood, Nigel ^b   Younge, Lisa ^c   Ghosh, Subrata ^d  

^a European Federation of Crohn's and Ulcerative Colitis Associations ^*  (United Kingdom)

^b National Association for Crohn's and Colitis Disease   (United Kingdom)

^c ST MARK S HOSPITAL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; disease; IBD consultation; Inflammatory bowel; Patient survey; Physician patient; Quality of life; relations; Ulcerative colitis

Indexed keywords

ADALIMUMAB; INFLIXIMAB;

ARTICLE; CONSULTATION; CROHN DISEASE; DAILY LIFE ACTIVITY; DOCTOR PATIENT RELATION; ENTERITIS; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL SOCIETY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 58849098418     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.07.002     Document Type: Article

References (4)

1. Ghosh S., and Mitchell R. Impact of inflammatory bowel disease on quality of life: results of he European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient urvey. J Crohn's Colitis 1 1 (2007) 10-20
2. Loftus EV, Colombel JF, Panaccione R, et al. Adalimumab sustains qualify-of-life improvements in patients with Crohn's disease: 2-year data from CHARM [P078]. Poster abstract presented at ECCO 2008, Lyon, France.
3. Hanauer S.B., Feagan B.G., Lichtenstein G.R., et al. Maintenance infliximab for Crohn's isease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
4. Moser G. Psychosomatic aspects of bowel diseases. Z Psychosom Med Psychother 52 2 (2006) 112-126